Evidence map›Paper›PMID 32407433›Full record

ArticleThe Journal of experimental medicine2020

Restriction of memory B cell differentiation at the germinal center B cell positive selection stage.

Amparo Toboso-Navasa, Arief Gunawan, Giulia Morlino, Rinako Nakagawa, Andrea Taddei, Djamil Damry, Yash Patel, Probir Chakravarty, Martin Janz, George Kassiotis and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Polarization of the memory B-cell response.Journal of leukocyte biology · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Regulation of BCR-mediated CaScience immunology · 2024
    Article
  13. Review
  14. Memory B cells.Nature reviews. Immunology · 2024
    Review
  15. Article
  16. Article
  17. Human intestinal B cells in inflammatory diseases.Nature reviews. Gastroenterology & hepatology · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Amparo Toboso-NavasaImmunity and Cancer, Francis Crick Institute, London, UK.
Arief GunawanImmunity and Cancer, Francis Crick Institute, London, UK.
Giulia MorlinoImmunity and Cancer, Francis Crick Institute, London, UK.
Rinako NakagawaImmunity and Cancer, Francis Crick Institute, London, UK.
Andrea TaddeiImmunity and Cancer, Francis Crick Institute, London, UK.
Djamil DamryImmunity and Cancer, Francis Crick Institute, London, UK.
Yash PatelRetroviral Immunology, Francis Crick Institute, London, UK.
Probir ChakravartyBioinformatics and Biostatistics, Francis Crick Institute, London, UK.
Martin JanzExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany.
George KassiotisRetroviral Immunology, Francis Crick Institute, London, UK.
Robert BrinkImmunology Division, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Martin EilersTheodor Boveri Institute and Comprehensive Cancer Center Mainfranken, Biocenter, University of Würzburg, Würzburg, Germany.
Dinis Pedro CaladoImmunity and Cancer, Francis Crick Institute, London, UK.
The Francis Crick Institute · GBGarvan Institute of Medical Research · AUKing's College London · GBMax Delbrück Center · DEUniversity of Würzburg · DE

Funding

Cancer Research UK FC001057Cancer Research UK FC001099Medical Research Council FC001057Medical Research Council FC001099Medical Research Council MR/J008060/1Wellcome Trust FC001057Wellcome Trust FC001099
6 · The paper itself

Abstract

Memory B cells (MBCs) are key for protection from reinfection. However, it is mechanistically unclear how germinal center (GC) B cells differentiate into MBCs. MYC is transiently induced in cells fated for GC expansion and plasma cell (PC) formation, so-called positively selected GC B cells. We found that these cells coexpressed MYC and MIZ1 (MYC-interacting zinc-finger protein 1 [ZBTB17]). MYC and MIZ1 are transcriptional activators; however, they form a transcriptional repressor complex that represses MIZ1 target genes. Mice lacking MYC-MIZ1 complexes displayed impaired cell cycle entry of positively selected GC B cells and reduced GC B cell expansion and PC formation. Notably, absence of MYC-MIZ1 complexes in positively selected GC B cells led to a gene expression profile alike that of MBCs and increased MBC differentiation. Thus, at the GC positive selection stage, MYC-MIZ1 complexes are required for effective GC expansion and PC formation and to restrict MBC differentiation. We propose that MYC and MIZ1 form a module that regulates GC B cell fate.

Indexed as

Cell DifferentiationImmunologic MemoryAICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesCell CycleCell ProliferationCyclin-Dependent Kinase Inhibitor p21Cytidine DeaminaseGerminal CenterMice, KnockoutProtein BindingProtein Inhibitors of Activated STATProto-Oncogene Proteins c-mycUbiquitin-Protein LigasesUp-RegulationAICDA (Activation-Induced Cytidine Deaminase)Cyclin-Dependent Kinase Inhibitor p21Cytidine DeaminaseMiz1 protein, mouseProtein Inhibitors of Activated STATProto-Oncogene Proteins c-mycUbiquitin-Protein Ligases

Identifiers

PMID32407433
PMCPMC7336312
OpenAlexW3024987730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.